DEO
Price
$100.25
Change
+$2.55 (+2.61%)
Updated
Nov 5 closing price
Capitalization
55.73B
Intraday BUY SELL Signals
EDVA
Price
$0.17
Change
-$0.02 (-10.53%)
Updated
Nov 5, 04:57 PM (EDT)
Capitalization
1.28M
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DEO vs EDVA

DEO vs EDVA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DEO vs. EDVA commentary
Nov 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DEO is a Hold and EDVA is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for DEO with price predictions
Nov 04, 2026

DEO's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for DEO moved out of overbought territory on October 26, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 instances where the indicator moved out of the overbought zone. In 18 of the 22 cases the stock moved lower in the days that followed. This puts the odds of a move down at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DEO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

DEO broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on DEO as a result. In 50 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.

The Moving Average Convergence Divergence (MACD) for DEO just turned positive on November 02, 2026. Looking at past instances where DEO's MACD turned positive, the stock continued to rise in 25 of 42 cases over the following month. The odds of a continued upward trend are 60%.

DEO moved above its 50-day moving average on October 13, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for DEO crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 4 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 25%.

Following a +6.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where DEO advanced for three days, in 116 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 42%.

The Aroon Indicator entered an Uptrend today. In 54 of 161 cases where DEO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 34%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. DEO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.126) is normal, around the industry mean (5.345). P/E Ratio (32.090) is within average values for comparable stocks, (71.042). Projected Growth (PEG Ratio) (0.545) is also within normal values, averaging (0.402). Dividend Yield (0.047) settles around the average of (0.091) among similar stocks. P/S Ratio (2.469) is also within normal values, averaging (5.308).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

A.I.Advisor
a Summary for EDVA with price predictions
Nov 04, 2026

EDVA in +5.95% Uptrend, advancing for three consecutive days on November 04, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where EDVA advanced for three days, in 165 of 193 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where EDVA's RSI Oscillator exited the oversold zone, 41 of 49 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Momentum Indicator moved above the 0 level on October 23, 2026. You may want to consider a long position or call options on EDVA as a result. In 63 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for EDVA just turned positive on October 06, 2026. Looking at past instances where EDVA's MACD turned positive, the stock continued to rise in 33 of 39 cases over the following month. The odds of a continued upward trend are 85%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for EDVA entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.081) is normal, around the industry mean (2.904). P/E Ratio (-0.008) is within average values for comparable stocks, (-0.738). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.314) among similar stocks. P/S Ratio (10.695) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 66 (best 1 - 100 worst), indicating steady price growth. EDVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EDVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
DEO vs EDVA: Fundamental Ratings
DEO
EDVA
OUTLOOK RATING
1..100
7945
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4266
P/E GROWTH RATING
1..100
159
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDVA's Valuation (50) in the null industry is in the same range as DEO (76) in the Beverages Alcoholic industry. This means that EDVA’s stock grew similarly to DEO’s over the last 12 months.

EDVA's Profit vs Risk Rating (100) in the null industry is in the same range as DEO (100) in the Beverages Alcoholic industry. This means that EDVA’s stock grew similarly to DEO’s over the last 12 months.

DEO's SMR Rating (98) in the Beverages Alcoholic industry is in the same range as EDVA (100) in the null industry. This means that DEO’s stock grew similarly to EDVA’s over the last 12 months.

DEO's Price Growth Rating (42) in the Beverages Alcoholic industry is in the same range as EDVA (66) in the null industry. This means that DEO’s stock grew similarly to EDVA’s over the last 12 months.

EDVA's P/E Growth Rating (9) in the null industry is in the same range as DEO (15) in the Beverages Alcoholic industry. This means that EDVA’s stock grew similarly to DEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DEOEDVA
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
48%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
42%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
60%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
78%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
34%
Bearish Trend 3 days ago
90%
COMPARISON
Comparison
Nov 06, 2026
Stock price -- (DEO: $100.25 vs. EDVA: $0.19)
Brand notoriety: DEO and EDVA are both not notable
DEO represents the Beverages: Alcoholic, while EDVA is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: DEO: 332% vs. EDVA: 11%
Market capitalization -- DEO: $55.73B vs. EDVA: $1.28M
DEO [@Beverages: Alcoholic] is valued at $55.73B. EDVA’s [@Biotechnology] market capitalization is $1.28M. The market cap for tickers in the [@Beverages: Alcoholic] industry ranges from $3.75K to $14.38T. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $137.5B. The average market capitalization across the [@Beverages: Alcoholic] industry is $6.62B. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DEO’s FA Score shows that 1 FA rating(s) are green while EDVA’s FA Score has 1 green FA rating(s).

  • DEO’s FA Score: 1 green, 4 red.
  • EDVA’s FA Score: 1 green, 4 red.
According to our system of comparison, EDVA is a better buy in the long-term than DEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DEO’s TA Score shows that 6 TA indicator(s) are bullish while EDVA’s TA Score has 4 bullish TA indicator(s).

  • DEO’s TA Score: 6 bullish, 4 bearish.
  • EDVA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, EDVA is a better buy in the short-term than DEO.

Price Growth

DEO (@Beverages: Alcoholic) experienced а +9.77% price change this week, while EDVA (@Biotechnology) price change was +9.32% for the same time period.

The average weekly price growth across all stocks in the @Beverages: Alcoholic industry was -7.27%. For the same industry, the average monthly price growth was -4.10%, and the average quarterly price growth was -20.10%.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.72%. For the same industry, the average monthly price growth was -14.23%, and the average quarterly price growth was -21.13%.

Reported Earning Dates

EDVA is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Beverages: Alcoholic (-7.27% weekly)

The alcoholic beverage market includes beer, wine, and spirits. From $230 billion in 2015, the industry has grown to around $250 billion by 2019. In recent years, alcoholic beverage makers have been looking to expand distribution and purchase channels, such as through online stores (e.g. e-commerce platform Drizly) and convenience stores. Anheuser-Busch In Bev and Diageo are major global alcoholic beverage companies, while U.S.-owned companies include Constellation Brands and Brown-Forman Corp. among several others.

@Biotechnology (-8.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

EDVA and

Correlation & Price change

A.I.dvisor tells us that EDVA and GPCR have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDVA and GPCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDVA
1D Price
Change %
EDVA100%
+3.23%
GPCR - EDVA
23%
Poorly correlated
+0.05%
DEO - EDVA
23%
Poorly correlated
+3.88%
BUD - EDVA
21%
Poorly correlated
+3.11%
EXOZ - EDVA
21%
Poorly correlated
-8.00%
STZ - EDVA
21%
Poorly correlated
+5.33%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSTR41.655.19
+14.23%
L.B. Foster Company
RAYA1.070.06
+5.94%
Erayak Power Solution Group Inc.
MAN46.931.47
+3.23%
ManpowerGroup
RANI0.570.02
+3.06%
Rani Therapeutics Holdings
WTFC156.120.75
+0.48%
Wintrust Financial Corp